To hear about similar clinical trials, please enter your email below
Trial Title:
Assessing the Time Demands of Cancer
NCT ID:
NCT05708703
Condition:
Metastatic Breast Cancer
Ovarian Cancer
Conditions: Official terms:
Ovarian Neoplasms
Conditions: Keywords:
ovarian cancer
metastatic breast cancer
time use
quality of life
cancer survivorship
Study type:
Observational
Overall status:
Active, not recruiting
Study design:
Time perspective:
Prospective
Summary:
A total of 80 individuals receiving treatment for metastatic breast or advanced stage
ovarian cancer will be asked to complete a baseline survey and install the mobile app on
their smartphone; carry the smartphone for 28 consecutive days while outside the home;
keep smartphone location and motion services active; confirm and correct (if needed)
smartphone-detected activities and trips; use the app interface to provide additional
information on activities and trips related to cancer treatment tasks; complete daily
surveys regarding well-being; and at the end of the 28 day period, complete an online
survey.
Criteria for eligibility:
Study pop:
Individuals currently undergoing treatment for metastatic breast or advanced stage
ovarian cancer.
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- 18 years of age or older
- Diagnosed with advanced stage (III, IV) ovarian (ovarian, fallopian tube or prmary
peritoneal) or metastatic breast cancer [do not need to be newly diagnosed]
- Currently receiving any type of therapy for their cancer [can be front-line,
maintenance therapy, or treatment for recurrence]
- Able to complete study tasks in English
- Able to provide voluntary informed consent
- Own an Android or iOS smartphone on which the operating system is version 9.0 or
higher for Android or 10.0 higher for iOS; or willing to use a researcher-provided
smartphone
Exclusion Criteria:
- Those who are currently incarcerated
- Have opted out of research contact
Gender:
All
Gender based:
Yes
Gender description:
Study is for patients with either breast or ovarian cancer.
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
University of Alabama
Address:
City:
Birmingham
Zip:
35294
Country:
United States
Facility:
Name:
Masonic Cancer Center - University of Minnesota
Address:
City:
Minneapolis
Zip:
55455
Country:
United States
Start date:
November 13, 2023
Completion date:
December 31, 2030
Lead sponsor:
Agency:
Masonic Cancer Center, University of Minnesota
Agency class:
Other
Collaborator:
Agency:
National Cancer Institute (NCI)
Agency class:
NIH
Source:
Masonic Cancer Center, University of Minnesota
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05708703